Bioprocessing - Upstream & Downstream

Matthew Zustiak from Thermo Fisher Scientific discusses the challenges of equipment choice for producing mAbs.

Efficient and reliable scale up is a key component of mAb production.

The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards

Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research.

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.

How can multi-column chromatography support companies as they set their sights on intensified bioprocesses?

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

How can smaller biopharma companies overcome the scale up and production complexities for microbial biomanufacturing?

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.